References & Disclaimers
Images are for illustrative purposes only. Not real patient data.
1. Data on file, Abbott Diabetes Care, Inc. Based on the number of users worldwide for the FreeStyle Libre portfolio compared to the number of users for
other leading personal use sensor-based glucose monitoring systems.
2. Based on signal range in Dexcom G6 CGM User Guide and Medtronic Guardian Connect System User Guide.
3. Among patient-applied sensors.
4. Data on file, Abbott Diabetes Care, Inc.
5. Dexcom G6 CGM User Guide and Medtronic Guardian Connect System User Guide.
6. Notifications will only be received when alarms are turned on and the sensor is within 10 meters unobstructed of the reading device.
7. Unger, J. et al, Postgrad Med. (2020): https://doi.org/10.1080/00325481.2020.1744393.
8. Bolinder, J. et al. Lancet (2016): http://doi.org/10.1016/S0140-6736(16)31535-5.
9. Hilliard, M., et al. Diabetes Technology & Therapeutics. (2019): https:/doi.org/10.1089/dia.2019.0142
10. Evans, M. et al. Diabetes Ther (2020): https://doi.org/10.1007/s13300-019-00720-0.
11. Fokkert, M. et al. BMJ Open Diab Res Care (2019): https://doi.org/10.1136/bmjdrc-2019-000809.
12. Alva, S. et al. Diabetes Ther. (2023); doi: 10.1007/s13300-023-01385-6.
13. Haak, T. et al. Diabetes Ther. (2017): https://doi.org/10.1007/s13300-016-0223-6.
14. Yaron, M. et al. Diabetes Care (2019): https://doi.org/10.2337/dc18-0166.
15. FreeStyle Libre 3 User Manual. FreeStyle Libre 3 demonstrates 7.8% overall MARD with 7.5% adult MARD and 8.6% paediatric MARD (age 6-17) in accuracy to YSI.
16. LibreView is ISO27001/27018/27701 certified and HITRUST CSF Certified.
17. NICE guideline NG17 (2015) Last updated: 17 August 2022; available at https://www.nice.org.uk/guidance/ng17. Accessed Jan 2023.
18. Real-time continuous glucose monitoring.
19. Multiple daily insulin injections.
20. NICE guideline NG28 (2015) Last updated: 29 June 2022; available at https://www.nice.org.uk/guidance/ng28. Accessed Jan 2023.
◊◊ The FreeStyle Libre 3 app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Sharing of glucose data requires registration with LibreView.
₼ The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose device data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
§ The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.LibreLinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
‡ 60-minute warm-up period required when applying the sensor.
₸ Sensor is water resistant in up to 1 metre (3 feet) of water for a maximum of 30 minutes. Do not immerse longer than 30 minutes. Not to be used above 10,000 feet.
Stay connected